Measuring skin elasticity in patients with lymphedema
Measuring Skin Elasticity in Lymphedema Patients
This study is testing a new device to measure skin elasticity in people with lymphedema to better understand the condition and how it changes over time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Beth Israel Deaconess Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT03313999 on ClinicalTrials.gov |
What this trial studies
This study uses a noninvasive device called a lymphedema indentometer to measure skin elasticity in patients diagnosed with lymphedema. By evaluating patients at Beth Israel Deaconess Medical Center, the study aims to characterize disease progression and compare local incidence rates with national data. The information gathered will also help assess the outcomes of surgical treatments for lymphedema. This approach provides a novel method for monitoring the condition without invasive procedures.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 with a diagnosis of lymphedema or those at risk of developing it.
Not a fit: Patients who do not have lymphedema or are not at risk for the condition may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of lymphedema, leading to improved patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies using noninvasive methods to assess skin conditions have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients evaluated by the Beth Israel Deaconess Medical Center Lymphedema team with a diagnosis of lymphedema OR determined to be at risk of developing Lymphedema in any of their extremities * Patients must be over 18 years of age * Patients must be willing and capable to provide informed consent * Patients must speak English Exclusion Criteria: * None
Where this trial is running
Boston, Massachusetts
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Dhruv Singhal, MD — Beth Israel Deaconess Medical Center
- Study coordinator: Angela Chen, BS
- Email: achen22@bidmc.harvard.edu
- Phone: 617-632-7043
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.